WESPAC Advisors SoCal’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

WESPAC Advisors SoCal’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1	Closed	-$753	–	292
2016 Q3	$753	Hold	1	–	–	﹤0.01%	275
2016 Q2	$801	Buy	+1	New	+$1.14K	﹤0.01%	270

Other funds holding NURO

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WESPAC Advisors SoCal's NURO Position: Q4 2016 in Review

WESPAC Advisors SoCal sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2016, closing a stake of 1 share — an estimated $753 sold.

WESPAC Advisors SoCal first reported a position in NURO in Q2 2016 and held it in 2 quarters. The position peaked at $801 in Q2 2016. 10 funds tracked by Wall St. Rank hold NURO as of Q4 2016.

WESPAC Advisors SoCal reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
WESPAC Advisors SoCal sold 1 NeuroMetrix, Inc. Common Stock share in Q4 2016, an estimated $753.
WESPAC Advisors SoCal first reported a position in NeuroMetrix, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
WESPAC Advisors SoCal's NeuroMetrix, Inc. Common Stock position peaked at $801 in Q2 2016.
10 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2016.

Based on WESPAC Advisors SoCal's 13F filing for Q4 2016, filed 13 Feb 2017.